1[1]ROMANIC A M,BURNS-KURTIS C L,GOUT B,et al.Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit[J].Life Sci,2001,68:799-814.
2[2]ETOH T,JOFFS C,DESCHAMPS A M,et al.Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs[J].Am J Physiol Heart Circ Physiol,2001,281:987-994.
3[3]LU L,GUNJA-SMITH Z,WOESSNER J F,et al.Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo[J].Am J Physiol Heart Circ Physiol,2000,279:601-609.
4[4]ROMANIC A M,HARRISON S M,BAO W.Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9[J].Cardiovasc Res,2002,54:549-558.
5[5]LINDSEY M,WEDIN K,BROWN M D,et al.Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia-reperfusion[J].Circulation,2001,103:2181-2187.
6[6]FRANGOGIANNIS N G,SMITH C W,ENTMAN M L.The inflammatory response in the ischaemic myocardium[J].Cardiovasc Res,2002,53:31-47.
7[7]KECK T,BALCOM J H,FERNANDEZ-DEL C C,et al.Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat[J].Gastroenterology,2002,122:188-201.
8[8]HOJO Y,IKEDA U,UENO S,et al.Expression of matrix metalloprotrinase in patients with acute myocardial infarction[J].Jpn Circ J,2001,65:71-75.
9[9]TAO Z Y,CAVASIN M A,YANG F,et al.Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice[J].Life Sci,2004,74:1561-1572.
10[10]HEYMANS S,LUTTUN A,NUYENS D,et al.Inhibition of plasminogen activators or matrix metaloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure[J].Nat Med,1999,5:1135-1142.
同被引文献11
1SAKURAI S,YAMAMOTO Y,TAMEI H,et al.Development of an ELISA for esRAGE and its application to type 1 diabetic patients[J].Diabetes Res Clin Pract,2006,73:158-165.
2RAUCCI A,CUGUSI S,ANTONELLI A,et al.A soluble form of the receptor for advanced glycation end products (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)[J].FASEB J,2008,22:3716-3727.
3TODD D M,HUBNER P J,HUDSON N,et al.Multicentre,prospective,randomized trial of 4 vs.6 French catheters in 410 patients undergoing coronary angiography[J].Catheter Cardiovasc Interv,2001,54:269-75.
4RYAN T J,ANDERSON J L,ANTMAN E M,et al.ACC/AHA guidelines for the management of patients with acute myocardial infarction:executive summary[J].Circulation,1996,94:2341-2450.
5TOUSOULIS D,KAMPOLI A M,STEFANADI E,et al.New biochemical markers in acute coronary syndromes[J].Curr Med Chem,2008,15:1288-1296.
6BUCCIARELLI L G,WENDT T,QU W,et al.RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice[J].Circulation,2002,106:2827-2835.
7ALESHIN A,ANANTHAKRISHNAN R,LI Q,et al.RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model[J].Am J Physiol Heart Circ Physiol,2008,294:H1823-H1832.
8BAICU C F,BRADSHAW A D,BOGGS J M,et al.Effects of inhibition of AGE-RAGE interaction in pressure-overload hypertrophy by treatment with sRAGE[J].J of Cardiac Fail,2008,14:S15-S15.
9LILIENSIEK B,WEIGAND M A,BIERHAUS A,et al.Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response[J].J Clin Invest,2004,113:1641-1650.
10KADEN J J,DEMPFLE C E,SUESELBECK T,et al.Time-dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction[J].Cardiology,2003,99:140-144.
